Alzheimers Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug (Donepezil, Rivastigmine, Galantamine, Memantine); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales)

Report Code: TIPRE00015800 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Alzheimers disease (AD) is a progressive, degenerative disorder that attacks the brain's nerve cells or neurons, resulting in loss of memory, thinking and language skills, and behavioral changes.

MARKET DYNAMICS

The alzheimer's drugs market is driving due to growing numbers of clinical trials focusing on preclinical along with increasing prevalence of AD and mild cognitive impairment across the globe. However, high failure rates of late-stage drugs which might hamper the market growth in the review period.

MARKET SCOPE

The "Alzheimers Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of alzheimer's drugs market with detailed market segmentation by drug, and distribution channel. The alzheimer's drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in alzheimer's drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The alzheimer's drugs market is segmented on the basis of drug, and distribution channel. On the basis of drug, the market is segmented into donepezil, rivastigmine, galantamine and memantine. On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy and online sales.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Alzheimers Drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Alzheimers Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Alzheimers Drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Alzheimers Drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the alzheimer's drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from alzheimer's drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for alzheimer's drugs market in the global market. Below mentioned is the list of few companies engaged in the alzheimer's drugs market.

The report also includes the profiles of key players in alzheimer's drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Pfizer, Inc.
  •  Janssen Pharmaceutical
  •  Novartis International AG
  •  Eisai Co. Ltd.
  •  Lundbeck A/S
  •  Teva Pharmaceuticals Industries Ltd.
  •  Eli Lilly and Company
  •  TauRx Pharmaceuticals Ltd
  •  VTV Therapeutics
  •  Hoffman-La Roche Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Alzheimers Drugs Market - By Drug
1.3.2 Alzheimers Drugs Market - By Distribution Channel
1.3.3 Alzheimers Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ALZHEIMER'S DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ALZHEIMER'S DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ALZHEIMER'S DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ALZHEIMER'S DRUGS - GLOBAL MARKET OVERVIEW
6.2. ALZHEIMER'S DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ALZHEIMER'S DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG
7.1. OVERVIEW
7.2. DRUG MARKET FORECASTS AND ANALYSIS
7.3. DONEPEZIL
7.3.1. Overview
7.3.2. Donepezil Market Forecast and Analysis
7.4. RIVASTIGMINE
7.4.1. Overview
7.4.2. Rivastigmine Market Forecast and Analysis
7.5. GALANTAMINE
7.5.1. Overview
7.5.2. Galantamine Market Forecast and Analysis
7.6. MEMANTINE
7.6.1. Overview
7.6.2. Memantine Market Forecast and Analysis
8. ALZHEIMER'S DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACY
8.3.1. Overview
8.3.2. Hospital Pharmacy Market Forecast and Analysis
8.4. RETAIL PHARMACY
8.4.1. Overview
8.4.2. Retail Pharmacy Market Forecast and Analysis
8.5. ONLINE SALES
8.5.1. Overview
8.5.2. Online Sales Market Forecast and Analysis
9. ALZHEIMER'S DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Alzheimers Drugs Market Overview
9.1.2 North America Alzheimers Drugs Market Forecasts and Analysis
9.1.3 North America Alzheimers Drugs Market Forecasts and Analysis - By Drug
9.1.4 North America Alzheimers Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Alzheimers Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Alzheimers Drugs Market
9.1.5.1.1 United States Alzheimers Drugs Market by Drug
9.1.5.1.2 United States Alzheimers Drugs Market by Distribution Channel
9.1.5.2 Canada Alzheimers Drugs Market
9.1.5.2.1 Canada Alzheimers Drugs Market by Drug
9.1.5.2.2 Canada Alzheimers Drugs Market by Distribution Channel
9.1.5.3 Mexico Alzheimers Drugs Market
9.1.5.3.1 Mexico Alzheimers Drugs Market by Drug
9.1.5.3.2 Mexico Alzheimers Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Alzheimers Drugs Market Overview
9.2.2 Europe Alzheimers Drugs Market Forecasts and Analysis
9.2.3 Europe Alzheimers Drugs Market Forecasts and Analysis - By Drug
9.2.4 Europe Alzheimers Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Alzheimers Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Alzheimers Drugs Market
9.2.5.1.1 Germany Alzheimers Drugs Market by Drug
9.2.5.1.2 Germany Alzheimers Drugs Market by Distribution Channel
9.2.5.2 France Alzheimers Drugs Market
9.2.5.2.1 France Alzheimers Drugs Market by Drug
9.2.5.2.2 France Alzheimers Drugs Market by Distribution Channel
9.2.5.3 Italy Alzheimers Drugs Market
9.2.5.3.1 Italy Alzheimers Drugs Market by Drug
9.2.5.3.2 Italy Alzheimers Drugs Market by Distribution Channel
9.2.5.4 Spain Alzheimers Drugs Market
9.2.5.4.1 Spain Alzheimers Drugs Market by Drug
9.2.5.4.2 Spain Alzheimers Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Alzheimers Drugs Market
9.2.5.5.1 United Kingdom Alzheimers Drugs Market by Drug
9.2.5.5.2 United Kingdom Alzheimers Drugs Market by Distribution Channel
9.2.5.6 Rest of Europe Alzheimers Drugs Market
9.2.5.6.1 Rest of Europe Alzheimers Drugs Market by Drug
9.2.5.6.2 Rest of Europe Alzheimers Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Alzheimers Drugs Market Overview
9.3.2 Asia-Pacific Alzheimers Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Alzheimers Drugs Market Forecasts and Analysis - By Drug
9.3.4 Asia-Pacific Alzheimers Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Alzheimers Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Alzheimers Drugs Market
9.3.5.1.1 Australia Alzheimers Drugs Market by Drug
9.3.5.1.2 Australia Alzheimers Drugs Market by Distribution Channel
9.3.5.2 China Alzheimers Drugs Market
9.3.5.2.1 China Alzheimers Drugs Market by Drug
9.3.5.2.2 China Alzheimers Drugs Market by Distribution Channel
9.3.5.3 India Alzheimers Drugs Market
9.3.5.3.1 India Alzheimers Drugs Market by Drug
9.3.5.3.2 India Alzheimers Drugs Market by Distribution Channel
9.3.5.4 Japan Alzheimers Drugs Market
9.3.5.4.1 Japan Alzheimers Drugs Market by Drug
9.3.5.4.2 Japan Alzheimers Drugs Market by Distribution Channel
9.3.5.5 South Korea Alzheimers Drugs Market
9.3.5.5.1 South Korea Alzheimers Drugs Market by Drug
9.3.5.5.2 South Korea Alzheimers Drugs Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Alzheimers Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Alzheimers Drugs Market by Drug
9.3.5.6.2 Rest of Asia-Pacific Alzheimers Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Alzheimers Drugs Market Overview
9.4.2 Middle East and Africa Alzheimers Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Alzheimers Drugs Market Forecasts and Analysis - By Drug
9.4.4 Middle East and Africa Alzheimers Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Alzheimers Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Alzheimers Drugs Market
9.4.5.1.1 South Africa Alzheimers Drugs Market by Drug
9.4.5.1.2 South Africa Alzheimers Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Alzheimers Drugs Market
9.4.5.2.1 Saudi Arabia Alzheimers Drugs Market by Drug
9.4.5.2.2 Saudi Arabia Alzheimers Drugs Market by Distribution Channel
9.4.5.3 U.A.E Alzheimers Drugs Market
9.4.5.3.1 U.A.E Alzheimers Drugs Market by Drug
9.4.5.3.2 U.A.E Alzheimers Drugs Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Alzheimers Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Alzheimers Drugs Market by Drug
9.4.5.4.2 Rest of Middle East and Africa Alzheimers Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Alzheimers Drugs Market Overview
9.5.2 South and Central America Alzheimers Drugs Market Forecasts and Analysis
9.5.3 South and Central America Alzheimers Drugs Market Forecasts and Analysis - By Drug
9.5.4 South and Central America Alzheimers Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Alzheimers Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Alzheimers Drugs Market
9.5.5.1.1 Brazil Alzheimers Drugs Market by Drug
9.5.5.1.2 Brazil Alzheimers Drugs Market by Distribution Channel
9.5.5.2 Argentina Alzheimers Drugs Market
9.5.5.2.1 Argentina Alzheimers Drugs Market by Drug
9.5.5.2.2 Argentina Alzheimers Drugs Market by Distribution Channel
9.5.5.3 Rest of South and Central America Alzheimers Drugs Market
9.5.5.3.1 Rest of South and Central America Alzheimers Drugs Market by Drug
9.5.5.3.2 Rest of South and Central America Alzheimers Drugs Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ALZHEIMER'S DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ALZHEIMER'S DRUGS MARKET, KEY COMPANY PROFILES
12.1. PFIZER, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JANSSEN PHARMACEUTICAL
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS INTERNATIONAL AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EISAI CO. LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LUNDBECK AS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TEVA PHARMACEUTICALS INDUSTRIES LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELI LILLY AND COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TAURX PHARMACEUTICALS LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. VTV THERAPEUTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HOFFMAN-LA ROCHE LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer, Inc.
2. Janssen Pharmaceutical
3. Novartis International AG
4. Eisai Co. Ltd.
5. Lundbeck A/S
6. Teva Pharmaceuticals Industries Ltd.
7. Eli Lilly and Company
8. TauRx Pharmaceuticals Ltd
9. VTV Therapeutics
10. Hoffman-La Roche Ltd.

TIPRE00015800
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking